Precision Dosing of Targeted Therapies Is Ready for Prime Time
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-20-4555
Abstract: Fixed dosing of oral targeted therapies is inadequate in the era of precision medicine. Personalized dosing, based on pharmacokinetic (PK) exposure, known as therapeutic drug monitoring (TDM), is rational and supported by increasing evidence. The… read more here.
Keywords: dosing targeted; therapies ready; targeted therapies; exposure ... See more keywords